FindTrial
Sign In

A clinical trial to study in HIV patients the effects of Homoeopathic medicine with the patients who do not require antiretroviral therapy

â??Prospective Evaluation Of A Homeopathic Preparation For The Treatment Of HIV Patientsâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/12/002228
Enrollment
30
Registered
2011-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV positive patients who are not on ART and has CD4 count more than or equal to 350 are given homeopathy treatment. Health Condition 2: D848- Other specified immunodeficiencies

Interventions

Intervention1: IMAID 30C and 50C potency: 30c for 3 months and 50c for next 3 months.: IMAID Dose: 6 pills 3 times in a day sublungually- oral administration. Study is duration 6 months.

Sponsors

Homeopathy India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group-18 to 65 years anf both sexes. 1.HIV sero +ve persons, treat- naive. 2. CD4 more than or equal to 350/cuml 3.VIRAL Load more than 500 copies/cuml 4. Expected life expectancy of more than 12 months.

Exclusion criteria

Exclusion criteria: HIV sero-negative persons 2. AIDs patients 3. Serious illness4. Viral loadless than 500 copies /cuml5. CD4 less than or equal to 350/cuml6. Patients on ART.7. Clinically suspected tuberculosis (CBC and ESR and X-Ray) who are on or eligible for AKT. 8. Clinically suspected and treated cancer 9. Psoriasis. 10. Lactating and pregnant women

Design outcomes

Primary

MeasureTime frame
1. Standardization of the new homoeopathy medicine 2. Safety evaluation. 3. Efficacy evaluation. 4. Recording of new symptoms and adverse effects, if any. Timepoint: 1. Standardization of the new homoeopathy medicine (It is a procedure, baseline and 6 months) 2. Safety evaluation( 6 months). 3. Efficacy evaluation(3 and 6 months). 4. Recording of new symptoms and adverse effects, if any(3 and 6 months).—

Secondary

MeasureTime frame
1. Reduction in HIV viral load compare Baseline 2. Increase in CD4 count by 20% 3. Increase in CD8 count form baseline To study change in CD4 percentage 4. To evaluate the percentage of patients for sustained reduction in viral load. Overall improvement in health (weight, improved appetite, less opportunistic infections) Timepoint: Clinical-Every 6weeks. Lab. parameters- three months. ( CD4 and viral Load)—

Countries

India

Contacts

Public ContactDr Rajesh Shah

Life Force Homeopathy

rajesh@lifeforce.in022-67978289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026